Updated GCP Modules - ICH E6 R2
On 15 December 2016, the International Council for Harmonisation (ICH) adopted the Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2), which reflects the evolving modernization of research (such as, increases in globalization, study complexity, and technological capabilities of clinical trials). Researchers, sponsors, and IRB members who comply with ICH E6 should be aware of the new guideline.
CITI Program GCP courses reflect the changes from ICH GCP E6(R2)
After the ICH GCP E6(R2) guideline was adopted, CITI Program's GCP modules that reference ICH E6 were revised to reflect the updated guideline. These GCP modules now specifically refer to the current guideline.
CITI Program has updated all affected GCP Modules in the following courses:
- GCP for Clinical Trials with Investigational Drugs and Medical Devices (U.S. FDA Focus)
- GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus)
- GCP FDA Refresher
- GCP ICH Refresher